Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 27 Jan 2006 |
| Genmab, announcement of prospectus | 12 Jan 2006 |
| InvestorService: Genmab, Appoints Annarie Lyles as Head of Business Development | 3 Jan 2006 |
| Genmab, HuMax-EGFr Awarded Fast Track Status from FDA | 3 Jan 2006 |
| Genmab, articles of association as per 13 December 2005 | 14 Dec 2005 |